Novartis broke ground on a 46,000-sq.-ft. radioligand therapy (RLT) manufacturing site in Denton Texas, its first in the state and fifth nationwide. Part of a $23 billion U.S. investment, the facility will enhance cancer treatment access and create jobs, strengthening Novartis’ nationwide RLT network and U.S.supply chain by 2028….
Novartis Breaks Ground On Denton, Texas Radioligand Therapy Site
0 Comments61 Min Read 
